- Report
- October 2026
- 376 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 372 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 372 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 196 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 387 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 339 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 368 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 587 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 359 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 392 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 458 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 376 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 305 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 472 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 257 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 364 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 331 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 265 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 385 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 302 Pages
Global
From €5388EUR$5,850USD£4,554GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more